Double benefit of long-acting somatostatin analogs in a patient with coexistence of acromegaly and ulcerative colitis


Yarman S. , Yalin G. Y. , Dogansen S. C. , Canbaz B., Tanrikulu S., Akyuz F.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, cilt.41, ss.559-562, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 41 Konu: 5
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1111/jcpt.12412
  • Dergi Adı: JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
  • Sayfa Sayıları: ss.559-562

Özet

What is known and objectiveSomatostatin analogs control GH/IGF-1 excess in acromegaly. Somatostatin receptors also mediate the complex effects of somatostatin on the gastrointestinal tract and may be defensive in inflammatory bowel diseases, such as ulcerative colitis. We present a patient who showed good response to long-acting octreotide (OCT-LAR) treatment in terms of both acromegaly and ulcerative colitis (UC).